Close
  Indian J Med Microbiol
 

Figure 2: (a, b, c, d) Effect of Lawsonia inermis (Henna) extract, individually or in combination with cyclophosphamide, on the growth response of B16F10 melanoma tumor. (a) Changes in Tumour Volume of B16F10 tumour-bearing mice. The Tumour Volume was expressed in mili meter (mm3); (b) change in volume doubling time on the growth of induced melanoma tumour. The volume doubling time was expressed in days; (c) Inhibition Rate increase as per dose dependent manner; (d) Effect of Lawsonia inermis alone and single (low and high) dose of Lawsonia inermis (Henna) extract along with CP as combination therapy, on the response of B16F10 Melanoma tumour bearing mice and mean survival time of C57BL/6 mice. The data represented Means ± S.E.M. (n= 6 mice) from triplicate experiments. **Significantly different from Tumour control group (TC) (P < 0.05) *Significantly different from Cyclophosphamide group (CP) (P < 0.05)

Figure 2: (a, b, c, d) Effect of Lawsonia inermis (Henna) extract, individually or in combination with cyclophosphamide, on the growth response of B16F10 melanoma tumor. (a) Changes in Tumour Volume of B16F10 tumour-bearing mice. The Tumour Volume was expressed in mili meter (mm3); (b) change in volume doubling time on the growth of induced melanoma tumour. The volume doubling time was expressed in days; (c) Inhibition Rate increase as per dose dependent manner; (d) Effect of Lawsonia inermis alone and single (low and high) dose of Lawsonia inermis (Henna) extract along with CP as combination therapy, on the response of B16F10 Melanoma tumour bearing mice and  mean survival time of C57BL/6 mice. The data represented Means ± S.E.M. (<i>n</i>= 6 mice) from triplicate experiments. **Significantly different from Tumour control group (TC) (<i>P</i> < 0.05) *Significantly different from Cyclophosphamide group (CP) (<i>P</i> < 0.05)